Congress Asset Management CO Abbott Laboratories Transaction History

Congress Asset Management CO

  • $14.3 Billion
  • Q3 2024

A detailed history of Congress Asset Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Congress Asset Management CO holds 3,818 shares of ABT stock, worth $438,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,818
Previous 6,179 38.21%
Holding current value
$438,153
Previous $642,000 32.24%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$100.07 - $118.13 $236,265 - $278,904
-2,361 Reduced 38.21%
3,818 $435,000
Q2 2024

Aug 02, 2024
BUY
$100.73 - $112.44 $135,381 - $151,119
1,344 Added 27.8%
6,179 $642,000
Q1 2024

Apr 11, 2024
SELL
$109.52 - $120.96 $229,225 - $253,169
-2,093 Reduced 30.21%
4,835 $549,000
Q4 2023

Mar 04, 2024
SELL
$90.19 - $110.4 $109,039 - $133,473
-1,209 Reduced 14.86%
6,928 $762,000
Q3 2023

Nov 01, 2023
SELL
$95.53 - $114.62 $71.7 Million - $86 Million
-750,166 Reduced 98.93%
8,137 $788,000
Q2 2023

Jul 27, 2023
SELL
$100.78 - $112.29 $1.3 Million - $1.45 Million
-12,936 Reduced 1.68%
758,303 $82.7 Million
Q1 2023

Apr 21, 2023
SELL
$96.86 - $114.01 $624,553 - $735,136
-6,448 Reduced 0.83%
771,239 $78.1 Million
Q4 2022

Jan 18, 2023
SELL
$95.06 - $111.52 $965,619 - $1.13 Million
-10,158 Reduced 1.29%
777,687 $0
Q3 2022

Nov 08, 2022
BUY
$96.76 - $112.03 $5.14 Million - $5.95 Million
53,125 Added 7.23%
787,845 $76.2 Million
Q2 2022

Aug 02, 2022
SELL
$102.07 - $123.37 $8.3 Million - $10 Million
-81,317 Reduced 9.96%
734,720 $79.8 Million
Q1 2022

Apr 20, 2022
BUY
$114.02 - $139.04 $807,261 - $984,403
7,080 Added 0.88%
816,037 $96.6 Million
Q4 2021

Jan 28, 2022
SELL
$115.53 - $141.46 $11.3 Million - $13.8 Million
-97,395 Reduced 10.75%
808,957 $114 Million
Q3 2021

Nov 08, 2021
BUY
$116.66 - $129.06 $8.4 Million - $9.3 Million
72,026 Added 8.63%
906,352 $107 Million
Q2 2021

Aug 05, 2021
BUY
$105.79 - $124.53 $1.67 Million - $1.97 Million
15,819 Added 1.93%
834,326 $96.7 Million
Q1 2021

May 05, 2021
BUY
$108.84 - $128.23 $785,607 - $925,564
7,218 Added 0.89%
818,507 $98.1 Million
Q4 2020

Jan 26, 2021
BUY
$105.0 - $114.42 $1.47 Million - $1.61 Million
14,031 Added 1.76%
811,289 $88.8 Million
Q3 2020

Nov 03, 2020
BUY
$91.64 - $111.29 $936,927 - $1.14 Million
10,224 Added 1.3%
797,258 $86.8 Million
Q2 2020

Jul 23, 2020
BUY
$76.57 - $98.0 $1.51 Million - $1.94 Million
19,782 Added 2.58%
787,034 $72 Million
Q1 2020

Apr 21, 2020
BUY
$62.82 - $91.86 $611,615 - $894,348
9,736 Added 1.29%
767,252 $60.5 Million
Q4 2019

Feb 10, 2020
BUY
$78.51 - $87.4 $48,283 - $53,751
615 Added 0.08%
757,516 $65.8 Million
Q3 2019

Nov 01, 2019
BUY
$81.84 - $88.74 $3,273 - $3,549
40 Added 0.01%
756,901 $63.3 Million
Q2 2019

Aug 07, 2019
BUY
$72.88 - $85.0 $1.24 Million - $1.44 Million
16,949 Added 2.29%
756,861 $63.7 Million
Q1 2019

May 08, 2019
BUY
$66.22 - $80.06 $2.6 Million - $3.14 Million
39,192 Added 5.59%
739,912 $59.1 Million
Q4 2018

Jan 25, 2019
BUY
$65.56 - $74.27 $39 Million - $44.2 Million
595,043 Added 563.08%
700,720 $50.7 Million
Q3 2018

Oct 26, 2018
SELL
$60.81 - $73.36 $12,466 - $15,038
-205 Reduced 0.19%
105,677 $7.75 Million
Q1 2018

May 11, 2018
SELL
$56.27 - $63.62 $53,569 - $60,566
-952 Reduced 0.89%
105,882 $6.34 Million
Q4 2017

Jan 30, 2018
SELL
$53.68 - $57.47 $5,475 - $5,861
-102 Reduced 0.1%
106,834 $6.1 Million
Q3 2017

Oct 17, 2017
BUY
$48.06 - $53.64 $5.14 Million - $5.74 Million
106,936
106,936 $5.71 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email